Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

13-Week Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated Steatosis (MASH) in Adults: A Randomized Control Trial

NCT06121999 is registered in ClinicalTrials.gov with Grand Valley State University as lead sponsor.

NCT NCT06121999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06121999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
13-Week Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated Steatosis (MASH) in Adults: A Randomized Control Trial
Lead sponsor
Grand Valley State University
Phase
Not applicable
Overall status
Completed
Start date
August 17, 2023
Completion date
November 1, 2024
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic associated-dysfunction steatohepatitis (mash), metabolic associated-dysfunction steatotic liver disease (masld)